Organon & Co.
OGN
$10.38
$0.707.23%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.81% | -6.72% | -0.38% | 4.15% | -0.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.81% | -6.72% | -0.38% | 4.15% | -0.06% |
| Cost of Revenue | 6.29% | -0.30% | 1.90% | 7.68% | 4.38% |
| Gross Profit | -5.86% | -11.18% | -2.08% | 1.76% | -3.00% |
| SG&A Expenses | 3.66% | -2.55% | 20.93% | -21.56% | -3.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.03% | -2.40% | 7.48% | -7.38% | 0.16% |
| Operating Income | -12.95% | -19.32% | -24.37% | 68.10% | -0.77% |
| Income Before Tax | -2.55% | -57.20% | 24.04% | 158.75% | -7.48% |
| Income Tax Expenses | 110.00% | -60.00% | 104.52% | -790.91% | 233.33% |
| Earnings from Continuing Operations | -25.64% | -56.72% | -80.04% | 518.97% | -19.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -25.64% | -56.72% | -80.04% | 518.97% | -19.42% |
| EBIT | -12.95% | -19.32% | -24.37% | 68.10% | -0.77% |
| EBITDA | -5.97% | -12.73% | -17.40% | 56.66% | 1.12% |
| EPS Basic | -26.40% | -57.08% | -80.20% | 514.46% | -20.04% |
| Normalized Basic EPS | -22.79% | -22.91% | -39.33% | 220.14% | -2.32% |
| EPS Diluted | -25.63% | -57.69% | -80.66% | 508.20% | -20.87% |
| Normalized Diluted EPS | -22.46% | -23.04% | -39.63% | 218.36% | -2.58% |
| Average Basic Shares Outstanding | 1.03% | 0.85% | 0.81% | 0.75% | 0.76% |
| Average Diluted Shares Outstanding | 0.60% | 1.02% | 1.28% | 1.33% | 1.03% |
| Dividend Per Share | -92.86% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.83% | 1.34% | 4.08% | -0.84% | 0.32% |